STE - STERIS plc

NYSE - NYSE Delayed Price. Currency in USD
146.25
-1.62 (-1.10%)
At close: 4:02PM EDT

146.29 +0.04 (0.02%)
After hours: 4:40PM EDT

Stock chart is not supported by your current browser
Previous Close147.87
Open148.17
Bid146.88 x 800
Ask147.04 x 900
Day's Range146.18 - 148.67
52 Week Range99.14 - 154.09
Volume454,583
Avg. Volume575,095
Market Cap12.36B
Beta (3Y Monthly)0.77
PE Ratio (TTM)41.08
EPS (TTM)3.56
Earnings DateAug 6, 2019 - Aug 12, 2019
Forward Dividend & Yield1.36 (0.92%)
Ex-Dividend Date2019-06-11
1y Target Est152.40
Trade prices are not sourced from all markets
  • Insulet (PODD) Soars to 52-Week High, Time to Cash Out?
    Zacks5 days ago

    Insulet (PODD) Soars to 52-Week High, Time to Cash Out?

    Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • GuruFocus.com6 days ago

    Five Companies Hit 52-Week Highs

    As of late, multiple companies managed to achieve yearly highs Continue reading...

  • TFX or STE: Which is a Better Investment Pick Right Now?
    Zacks8 days ago

    TFX or STE: Which is a Better Investment Pick Right Now?

    STERIS (STE) scores higher than Teleflex (TFX) when it comes to valuation and one-year price performance.

  • Could The STERIS plc (NYSE:STE) Ownership Structure Tell Us Something Useful?
    Simply Wall St.8 days ago

    Could The STERIS plc (NYSE:STE) Ownership Structure Tell Us Something Useful?

    Every investor in STERIS plc (NYSE:STE) should be aware of the most powerful shareholder groups. Generally speaking...

  • Here’s What Hedge Funds Think About Steris Plc (STE)
    Insider Monkeylast month

    Here’s What Hedge Funds Think About Steris Plc (STE)

    It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]

  • What To Know Before Buying STERIS plc (NYSE:STE) For Its Dividend
    Simply Wall St.last month

    What To Know Before Buying STERIS plc (NYSE:STE) For Its Dividend

    Could STERIS plc (NYSE:STE) be an attractive dividend share to own for the long haul? Investors are often drawn to...

  • Steris (STE) Up 7.5% Since Last Earnings Report: Can It Continue?
    Zackslast month

    Steris (STE) Up 7.5% Since Last Earnings Report: Can It Continue?

    Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Markitlast month

    See what the IHS Markit Score report has to say about Steris plc.

    Steris plc NYSE:STEView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for STE with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.13 billion over the last one-month into ETFs that hold STE are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GuruFocus.com2 months ago

    Steris Ltd (STE) President & CEO Walter M Rosebrough Jr Sold $15.8 million of Shares

    President & CEO of Steris Ltd (NYSE:STE) Walter M Rosebrough Jr sold 119,000 shares of STE on 05/31/2019 at an average price of $132.56 a share.

  • Is STERIS plc's (NYSE:STE) 9.6% ROE Better Than Average?
    Simply Wall St.2 months ago

    Is STERIS plc's (NYSE:STE) 9.6% ROE Better Than Average?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of STE.N earnings conference call or presentation 14-May-19 2:00pm GMT

    Q4 2019 Steris plc Earnings Call

  • Steris (STE) Q4 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Steris (STE) Q4 2019 Earnings Call Transcript

    STE earnings call for the period ending March 31, 2019.

  • CNBC2 months ago

    Stocks making the biggest moves midday: Coca-Cola, Disney, Deckers Outdoor & more

    These are the stocks posting the largest moves midday.

  • Are Insiders Selling STERIS plc (NYSE:STE) Stock?
    Simply Wall St.2 months ago

    Are Insiders Selling STERIS plc (NYSE:STE) Stock?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • STERIS (STE) Q4 Earnings Surpass Estimates, Margins Rise
    Zacks2 months ago

    STERIS (STE) Q4 Earnings Surpass Estimates, Margins Rise

    STERIS (STE) witnesses solid revenue growth across each of its operating segments in the reported quarter.

  • What You'll Want to Know About Steris' Solid Q4 Earnings Results
    Motley Fool2 months ago

    What You'll Want to Know About Steris' Solid Q4 Earnings Results

    The healthcare company delivered solid growth in Q4 and beat Wall Street estimates on both the top and bottom lines.

  • Steris (STE) Q4 Earnings and Revenues Surpass Estimates
    Zacks2 months ago

    Steris (STE) Q4 Earnings and Revenues Surpass Estimates

    Steris (STE) delivered earnings and revenue surprises of 6.25% and 4.62%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    Steris: Fiscal 4Q Earnings Snapshot

    On a per-share basis, the Derby, Britain-based company said it had profit of $1.27. Earnings, adjusted for one-time gains and costs, were $1.53 per share. The results topped Wall Street expectations. The ...

  • GlobeNewswire2 months ago

    STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year

    Dublin, Ireland, May 13, 2019 (GLOBE NEWSWIRE) -- - STERIS plc (STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2019 fourth quarter ended March 31, 2019.  Revenue as reported for the quarter increased 7% to $768.2 million compared with $716.0 million in the fourth quarter of fiscal 2018, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 9% for the fourth quarter of fiscal 2019.

  • What's in Store for Aurora Cannabis (ACB) in Q3 Earnings?
    Zacks2 months ago

    What's in Store for Aurora Cannabis (ACB) in Q3 Earnings?

    Continued execution of consumer and medical strategies, launch of new products and strong international footprint are likely to aid Aurora Cannabis (ACB) in Q3.

  • Steris (STE) Earnings Expected to Grow: Should You Buy?
    Zacks2 months ago

    Steris (STE) Earnings Expected to Grow: Should You Buy?

    Steris (STE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Can Core Business Unit Fuel McKesson (MCK) Q4 Earnings?
    Zacks3 months ago

    Can Core Business Unit Fuel McKesson (MCK) Q4 Earnings?

    Anticipated growth across core business unit and solid show by Medical Surgical and European Pharmaceutical Solutions is likely to aid McKesson's (MCK) Q4 earnings. However, rising costs might be a dampener.

  • What's in Store for Cardinal Health (CAH) in Q3 Earnings?
    Zacks3 months ago

    What's in Store for Cardinal Health (CAH) in Q3 Earnings?

    Better-than-expected performance at Pharmaceutical and Medical segments and diverse product portfolio is likely to aid Cardinal Health (CAH) in Q3 earnings. However, stiff competition might play spoilsport.